168 related articles for article (PubMed ID: 25737008)
1. Isolation, synthesis and anti-hepatitis B virus evaluation of p-hydroxyacetophenone derivatives from Artemisia capillaris.
Zhao Y; Geng CA; Chen H; Ma YB; Huang XY; Cao TW; He K; Wang H; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2015 Apr; 25(7):1509-14. PubMed ID: 25737008
[TBL] [Abstract][Full Text] [Related]
2. Polyacetylenes and anti-hepatitis B virus active constituents from Artemisia capillaris.
Zhao Y; Geng CA; Sun CL; Ma YB; Huang XY; Cao TW; He K; Wang H; Zhang XM; Chen JJ
Fitoterapia; 2014 Jun; 95():187-93. PubMed ID: 24685503
[TBL] [Abstract][Full Text] [Related]
3. UFLC/MS-IT-TOF guided isolation of anti-HBV active chlorogenic acid analogues from Artemisia capillaris as a traditional Chinese herb for the treatment of hepatitis.
Zhao Y; Geng CA; Ma YB; Huang XY; Chen H; Cao TW; He K; Wang H; Zhang XM; Chen JJ
J Ethnopharmacol; 2014 Oct; 156():147-54. PubMed ID: 25219603
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of chemical compound isolated from Artemisia morrisonensis against hepatitis B virus in vitro.
Huang TJ; Liu SH; Kuo YC; Chen CW; Chou SC
Antiviral Res; 2014 Jan; 101():97-104. PubMed ID: 24269476
[TBL] [Abstract][Full Text] [Related]
5. Anti-hepatitis B virus effects of the traditional Chinese herb Artemisia capillaris and its active enynes.
Geng CA; Yang TH; Huang XY; Yang J; Ma YB; Li TZ; Zhang XM; Chen JJ
J Ethnopharmacol; 2018 Oct; 224():283-289. PubMed ID: 29890315
[TBL] [Abstract][Full Text] [Related]
6. Three new anti-HBV active constituents from the traditional Chinese herb of Yin-Chen (Artemisia scoparia).
Geng CA; Huang XY; Chen XL; Ma YB; Rong GQ; Zhao Y; Zhang XM; Chen JJ
J Ethnopharmacol; 2015 Dec; 176():109-17. PubMed ID: 26505294
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Guo RH; Zhang XM; Chen JJ
Bioorg Med Chem; 2012 May; 20(9):2877-88. PubMed ID: 22472044
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and bioevaluation of paeonol derivatives as potential anti-HBV agents.
Huang TJ; Chuang H; Liang YC; Lin HH; Horng JC; Kuo YC; Chen CW; Tsai FY; Yen SC; Chou SC; Hsu MH
Eur J Med Chem; 2015 Jan; 90():428-35. PubMed ID: 25461891
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors.
Geng CA; Huang XY; Ma YB; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2015 Apr; 25(7):1568-71. PubMed ID: 25737009
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
Liu S; Wei W; Li Y; Liu X; Cao X; Lei K; Zhou M
Eur J Med Chem; 2015 May; 95():473-82. PubMed ID: 25847765
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure-activity relationships and biological evaluation of dehydroandrographolide and andrographolide derivatives as novel anti-hepatitis B virus agents.
Chen H; Ma YB; Huang XY; Geng CA; Zhao Y; Wang LJ; Guo RH; Liang WJ; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2014 May; 24(10):2353-9. PubMed ID: 24731274
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents.
Guo RH; Zhang Q; Ma YB; Luo J; Geng CA; Wang LJ; Zhang XM; Zhou J; Jiang ZY; Chen JJ
Eur J Med Chem; 2011 Jan; 46(1):307-19. PubMed ID: 21145140
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2012 May; 22(10):3473-9. PubMed ID: 22520261
[TBL] [Abstract][Full Text] [Related]
14. Isolation and structure of vanitaracin A, a novel anti-hepatitis B virus compound from Talaromyces sp.
Matsunaga H; Kamisuki S; Kaneko M; Yamaguchi Y; Takeuchi T; Watashi K; Sugawara F
Bioorg Med Chem Lett; 2015 Oct; 25(19):4325-8. PubMed ID: 26271586
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents.
Qiu J; Xu B; Huang Z; Pan W; Cao P; Liu C; Hao X; Song B; Liang G
Bioorg Med Chem; 2011 Sep; 19(18):5352-60. PubMed ID: 21872478
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of hemslecin A derivatives: a new class of hepatitis B virus inhibitors.
Guo RH; Geng CA; Huang XY; Ma YB; Zhang Q; Wang LJ; Zhang XM; Zhang RP; Chen JJ
Bioorg Med Chem Lett; 2013 Mar; 23(5):1201-5. PubMed ID: 23385212
[TBL] [Abstract][Full Text] [Related]
17. Anti-HBV agents. Part 3: preliminary structure-activity relationships of tetra-acylalisol A derivatives as potent hepatitis B virus inhibitors.
Zhang Q; Jiang ZY; Luo J; Ma YB; Liu JF; Guo RH; Zhang XM; Zhou J; Niu W; Du FF; Li L; Li C; Chen JJ
Bioorg Med Chem Lett; 2009 Dec; 19(23):6659-65. PubMed ID: 19853440
[TBL] [Abstract][Full Text] [Related]
18. Anti-hepatitis B virus active constituents from Swertia chirayita.
Zhou NJ; Geng CA; Huang XY; Ma YB; Zhang XM; Wang JL; Chen JJ
Fitoterapia; 2015 Jan; 100():27-34. PubMed ID: 25447162
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of new N(4)-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine derivatives as potent anti-HBV agents.
Lv Z; He W; Tian X; Kang J; Liu Y; Peng Y; Zheng L; Wang Q; Yu W; Chang J
Eur J Med Chem; 2015 Aug; 101():103-10. PubMed ID: 26119991
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
Huang TJ; Yang CL; Kuo YC; Chang YC; Yang LM; Chou BH; Lin SJ
Bioorg Med Chem; 2015 Feb; 23(4):720-8. PubMed ID: 25600408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
